{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:49Z","timestamp":1787020789236,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13000-015-0441-7","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T18:57:49Z","timestamp":1449601069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases"],"prefix":"10.1186","volume":"10","author":[{"given":"Mark","family":"Kriegsmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Muley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tavernar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Dienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Herpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Warth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"441_CR1","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IARC; Lyon, France; 2015."},{"issue":"4","key":"441_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00063198-200107000-00011","volume":"7","author":"KY Yoneda","year":"2001","unstructured":"Yoneda KY, Louie S, Shelton DK. Mediastinal tumors. Curr Opin Pulm Med. 2001;7(4):226\u201333.","journal-title":"Curr Opin Pulm Med"},{"issue":"10","key":"441_CR3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","volume":"9","author":"J Huang","year":"2014","unstructured":"Huang J, Ahmad U, Antonicelli A, Catlin AC, Fang W, Gomez D, et al. Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors. J Thorac Oncol. 2014;9(10):1573\u20138. doi: 10.1097\/JTO.0000000000000269 .","journal-title":"J Thorac Oncol"},{"key":"441_CR4","author":"T Hishida","year":"2015","unstructured":"Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2015. doi: 10.1093\/ejcts\/ezv239 .","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"441_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12032-014-0044-2","volume":"31","author":"J Syrios","year":"2014","unstructured":"Syrios J, Diamantis N, Fergadis E, Katsaros L, Logothetis M, Iakovidou I, et al. Advances in thymic carcinoma diagnosis and treatment: a review of literature. Med Oncol. 2014;31(7):44. doi: 10.1007\/s12032-014-0044-2 .","journal-title":"Med Oncol"},{"issue":"1","key":"441_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thorsurg.2010.08.010","volume":"21","author":"A Marx","year":"2011","unstructured":"Marx A, Rieker R, Toker A, Langer F, Strobel P. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin. 2011;21(1):25\u201331. doi: 10.1016\/j.thorsurg.2010.08.010 . v-vi.","journal-title":"Thorac Surg Clin"},{"issue":"5","key":"441_CR7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","volume":"9","author":"A Marx","year":"2014","unstructured":"Marx A, Strobel P, Badve SS, Chalabreysse L, Chan JK, Chen G, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9(5):596\u2013611. doi: 10.1097\/JTO.0000000000000154 .","journal-title":"J Thorac Oncol"},{"issue":"3","key":"441_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","volume":"202","author":"CC Pan","year":"2004","unstructured":"Pan CC, Chen PC, Chiang H. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol. 2004;202(3):375\u201381. doi: 10.1002\/path.1514 .","journal-title":"J Pathol"},{"issue":"1","key":"441_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","volume":"128","author":"K Nakagawa","year":"2005","unstructured":"Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest. 2005;128(1):140\u20134. doi: 10.1378\/chest.128.1.140 .","journal-title":"Chest"},{"issue":"5","key":"441_CR10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PAI.0b013e318297cdb5","volume":"22","author":"JR Asirvatham","year":"2014","unstructured":"Asirvatham JR, Esposito MJ, Bhuiya TA. Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Appl Immunohistochem Mol Morphol. 2014;22(5):372\u20136. doi: 10.1097\/PAI.0b013e318297cdb5 .","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"441_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00428-013-1371-y","volume":"462","author":"V Thomas de Montpreville","year":"2013","unstructured":"Thomas de Montpreville V, Ghigna MR, Lacroix L, Besse B, Broet P, Dartevelle P, et al. Thymic carcinomas: clinicopathologic study of 37 cases from a single institution. Virchows Arch. 2013;462(3):307\u201313. doi: 10.1007\/s00428-013-1371-y .","journal-title":"Virchows Arch"},{"issue":"2","key":"441_CR12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2559.2002.01328.x","volume":"40","author":"S Pomplun","year":"2002","unstructured":"Pomplun S, Wotherspoon AC, Shah G, Goldstraw P, Ladas G, Nicholson AG. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology. 2002;40(2):152\u20138.","journal-title":"Histopathology"},{"issue":"2","key":"441_CR13","first-page":"268","volume":"145","author":"T Hishima","year":"1994","unstructured":"Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N, et al. CD5 expression in thymic carcinoma. Am J Pathol. 1994;145(2):268\u201375.","journal-title":"Am J Pathol"},{"issue":"Suppl 5","key":"441_CR14","first-page":"S489","volume":"6","author":"ER Tang","year":"2014","unstructured":"Tang ER, Schreiner AM, Pua BB. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC\/ATS\/ERS). J Thorac Dis. 2014;6 Suppl 5:S489\u2013501. doi: 10.3978\/j.issn.2072-1439.2014.09.12 .","journal-title":"J Thorac Dis"},{"issue":"12","key":"441_CR15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/PAS.0b013e3181f7dae3","volume":"34","author":"J Terry","year":"2010","unstructured":"Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34(12):1805\u201311. doi: 10.1097\/PAS.0b013e3181f7dae3 .","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"441_CR16","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138\u201340.","journal-title":"Pathologe"},{"issue":"2","key":"441_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2000-9868","volume":"48","author":"DA Chung","year":"2000","unstructured":"Chung DA. Thymic carcinoma--analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg. 2000;48(2):114\u20139. doi: 10.1055\/s-2000-9868 .","journal-title":"Thorac Cardiovasc Surg"},{"issue":"5","key":"441_CR18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5858\/2004-128-538-TSOKCI","volume":"128","author":"KJ Butnor","year":"2004","unstructured":"Butnor KJ, Burchette JL, Sporn TA, Hammar SP, Roggli VL. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Arch Pathol Lab Med. 2004;128(5):538\u201343. doi: 10.1043\/1543-2165(2004)128<538:TSOKCI>2.0.CO;2 .","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"441_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.53.9","volume":"53","author":"A Hayashi","year":"2013","unstructured":"Hayashi A, Fumon T, Miki Y, Sato H, Yoshino T, Takahashi K. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma. J Clin Exp Hematop. 2013;53(1):9\u201319.","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"441_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.lungcan.2008.03.035","volume":"62","author":"M Tsuchida","year":"2008","unstructured":"Tsuchida M, Umezu H, Hashimoto T, Shinohara H, Koike T, Hosaka Y, et al. Absence of gene mutations in KIT-positive thymic epithelial tumors. Lung Cancer. 2008;62(3):321\u20135. doi: 10.1016\/j.lungcan.2008.03.035 .","journal-title":"Lung Cancer"},{"issue":"2","key":"441_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00129039-200306000-00002","volume":"11","author":"RS Saad","year":"2003","unstructured":"Saad RS, Landreneau RJ, Liu Y, Silverman JF. Utility of immunohistochemistry in separating thymic neoplasms from germ cell tumors and metastatic lung cancer involving the anterior mediastinum. Appl Immunohistochem Mol Morphol. 2003;11(2):107\u201312.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"441_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1368-5031.2006.00742.x","volume":"60","author":"A Yaren","year":"2006","unstructured":"Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, et al. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Int J Clin Pract. 2006;60(6):675\u201382. doi: 10.1111\/j.1368-5031.2006.00742.x .","journal-title":"Int J Clin Pract"},{"issue":"5\u20136","key":"441_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000081386","volume":"25","author":"P Micke","year":"2004","unstructured":"Micke P, Hengstler JG, Albrecht H, Faldum A, Bittinger F, Becker K, et al. c-kit expression in adenocarcinomas of the lung. Tumour Biol. 2004;25(5\u20136):235\u201342. doi: 10.1159\/000081386 .","journal-title":"Tumour Biol"},{"issue":"2","key":"441_CR24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3892\/ol.2014.2173","volume":"8","author":"H Xiao","year":"2014","unstructured":"Xiao H, Wang J, Liu Y, Li L. Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncol Lett. 2014;8(2):582\u20138. doi: 10.3892\/ol.2014.2173 .","journal-title":"Oncol Lett"},{"issue":"12","key":"441_CR25","first-page":"4491","volume":"31","author":"E Herpel","year":"2011","unstructured":"Herpel E, Jensen K, Muley T, Warth A, Schnabel PA, Meister M, et al. The cancer stem cell antigens CD133, BCRP1\/ABCG2 and CD117\/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res. 2011;31(12):4491\u2013500.","journal-title":"Anticancer Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-015-0441-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T11:39:14Z","timestamp":1653737954000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.diagnosticpathology.org\/content\/10\/1\/210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1186\/s13000-015-0441-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"210"}}